Cargando…

Novel blood‐based tumor mutation algorithm and nomogram predict survival of immune checkpoint inhibitor in non‐small‐cell lung cancer: Results from two multicenter, randomized clinical trials

Detalles Bibliográficos
Autores principales:	Yu, Yunfang, Chen, Yongjian, Li, Anlin, Ou, Qiyun, Li, Qingjian, Gu, Yang, Lin, Dagui, Zhang, Wenda, Wang, Jingshu, Tang, Xudong, Li, Zhihua, Hu, Hai, Yao, Herui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403831/ https://www.ncbi.nlm.nih.gov/pubmed/32508050 http://dx.doi.org/10.1002/ctm2.53

Ejemplares similares

Association of Immune Checkpoint Inhibitor Therapy With Survival in Patients With Cancers With MUC16 Variants
por: Yu, Yunfang, et al.
Publicado: (2020)

Association of immune checkpoint inhibitor with survival in patients with cancers with protein tyrosine phosphatase receptor T mutation
por: He, Zifan, et al.
Publicado: (2020)

Joint association of patients’ sex and PD‐L1 expression with overall survival benefits and tumor‐immune microenvironment in immune checkpoint inhibitors for cancers
por: Li, Anlin, et al.
Publicado: (2020)

Association of Survival and Immune-Related Biomarkers With Immunotherapy in Patients With Non–Small Cell Lung Cancer: A Meta-analysis and Individual Patient–Level Analysis
por: Yu, Yunfang, et al.
Publicado: (2019)

Association of survival and genomic mutation signature with immunotherapy in patients with hepatocellular carcinoma
por: Ou, Qiyun, et al.
Publicado: (2020)

Association of Long Noncoding RNA Biomarkers With Clinical Immune Subtype and Prediction of Immunotherapy Response in Patients With Cancer
por: Yu, Yunfang, et al.
Publicado: (2020)

Clinical Evidence of Chemotherapy or Endocrine Therapy Maintenance in Patients with Metastatic Breast Cancer: Meta-Analysis of Randomized Clinical Trials and Propensity Score Matching of Multicenter Cohort Study
por: Ren, Wei, et al.
Publicado: (2022)

Magnetic resonance imaging radiomics predicts preoperative axillary lymph node metastasis to support surgical decisions and is associated with tumor microenvironment in invasive breast cancer: A machine learning, multicenter study
por: Yu, Yunfang, et al.
Publicado: (2021)

Effect of prior cancer history on survival of patients with esophageal carcinoma: a propensity score matching, population-based study
por: Liu, Jingwen, et al.
Publicado: (2022)

Development and Validation of a Preoperative Magnetic Resonance Imaging Radiomics–Based Signature to Predict Axillary Lymph Node Metastasis and Disease-Free Survival in Patients With Early-Stage Breast Cancer
por: Yu, Yunfang, et al.
Publicado: (2020)

Neoadjuvant camrelizumab, nab-paclitaxel, and carboplatin in patients with stage IB-IIIA non-small cell lung cancer (NANE-LC): a study protocol of prospective, single-arm, multicenter, phase II study
por: Zhou, Haiyu, et al.
Publicado: (2021)

A Comprehensive Analysis of Programmed Cell Death-Associated Genes for Tumor Microenvironment Evaluation Promotes Precise Immunotherapy in Patients with Lung Adenocarcinoma
por: Huang, Yunxi, et al.
Publicado: (2023)

Immune gene patterns and characterization of the tumor immune microenvironment associated with cancer immunotherapy efficacy
por: Lin, Lili, et al.
Publicado: (2023)

Development and validation of a nomogram in survival prediction among advanced breast cancer patients
por: Zhao, Jianli, et al.
Publicado: (2020)

Machine learning radiomics of magnetic resonance imaging predicts recurrence-free survival after surgery and correlation of LncRNAs in patients with breast cancer: a multicenter cohort study
por: Yu, Yunfang, et al.
Publicado: (2023)

LncRNA Uc003xsl.1-Mediated Activation of the NFκB/IL8 Axis Promotes Progression of Triple-Negative Breast Cancer
por: Xu, Ying, et al.
Publicado: (2022)

Development and validation of prognostic nomograms for patients with colon neuroendocrine neoplasms
por: Xu, Ruitong, et al.
Publicado: (2021)

A novel nutrition-related nomogram for the survival prediction of colorectal cancer-results from a multicenter study
por: Ruan, Guo-Tian, et al.
Publicado: (2023)

A Prognostic Risk Score Based on Hypoxia-, Immunity-, and Epithelialto-Mesenchymal Transition-Related Genes for the Prognosis and Immunotherapy Response of Lung Adenocarcinoma
por: Ouyang, Wenhao, et al.
Publicado: (2022)

Development and validation of a nomogram for predicting recurrence-free survival in endometrial cancer: a multicenter study
por: Li, Yinuo, et al.
Publicado: (2023)

Establishment and validation of nomogram for predicting immuno checkpoint inhibitor related pneumonia
por: Li, Xiaoqi, et al.
Publicado: (2022)

Development and Validation of a Nomogram for Predicting Overall Survival to Concurrent Chemoradiotherapy in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma
por: Wang, Chenyu, et al.
Publicado: (2022)

RYBP Inhibits Progression and Metastasis of Lung Cancer by Suppressing EGFR Signaling and Epithelial-Mesenchymal Transition()()
por: Dinglin, Xiaoxiao, et al.
Publicado: (2017)

Deep learning magnetic resonance imaging predicts platinum sensitivity in patients with epithelial ovarian cancer
por: Lei, Ruilin, et al.
Publicado: (2022)

A novel nomogram and prognostic factor for metastatic renal cell carcinoma survival in the era of immune checkpoint inhibitors (ICIs)
por: Alradhi, Mohammed, et al.
Publicado: (2023)

Nomogram to Predict the Overall Survival of Colorectal Cancer Patients: A Multicenter National Study
por: Borumandnia, Nasrin, et al.
Publicado: (2021)

A Nomogram for the Prediction of Progression and Overall Survival in Childhood Acute Lymphoblastic Leukemia
por: Zhang, Dan, et al.
Publicado: (2020)

Nomogram for predicting disease-free survival among a multicenter cohort of Chinese patients with locally advanced rectal cancer
por: Li, Zhen-Hui, et al.
Publicado: (2019)

A Nomogram for Predicting Event-Free Survival in Childhood Acute Lymphoblastic Leukemia: A Multicenter Retrospective Study
por: He, Yun-yan, et al.
Publicado: (2022)

Survival nomograms for stage III colorectal cancer
por: Li, Chenglong, et al.
Publicado: (2018)

Impact of body mass index and its change on survival outcomes in patients with early breast cancer: A pooled analysis of individual-level data from BCIRG-001 and BCIRG-005 trials
por: Chen, Haizhu, et al.
Publicado: (2023)

A Multicenter Clinical Study of the Automated Fundus Screening Algorithm
por: Li, Fei, et al.
Publicado: (2022)

Prognostic Nomograms for Predicting Overall Survival and Cancer‐Specific Survival of Patients With Malignant Pheochromocytoma and Paraganglioma
por: Zheng, Lei, et al.
Publicado: (2021)

A Nomogram to Predict Recurrence-Free Survival Following Surgery for Vestibular Schwannoma
por: Zhang, Zehan, et al.
Publicado: (2022)

Survival Nomogram for Curatively Resected Korean Gastric Cancer Patients: Multicenter Retrospective Analysis with External Validation
por: Eom, Bang Wool, et al.
Publicado: (2015)

A nomogram for predicting mortality in patients with COVID-19 and solid tumors: a multicenter retrospective cohort study
por: Liu, Chao, et al.
Publicado: (2020)

Radiomic and clinical data integration using machine learning predict the efficacy of anti-PD-1 antibodies-based combinational treatment in advanced breast cancer: a multicentered study
por: Zhao, Jianli, et al.
Publicado: (2023)

Construction and Validation of TACE Therapeutic Efficacy by ALR Score and Nomogram: A Large, Multicenter Study
por: Li, Han, et al.
Publicado: (2023)

A Noninvasive Tool Based on Magnetic Resonance Imaging Radiomics for the Preoperative Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer
por: Li, Chenchen, et al.
Publicado: (2022)

An immunoscore nomogram for predicting survival in patients with oesophageal cancer
por: Li, Gaoming, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dcu4s8l0b9hcglng7pbm2njhln